n-(3-pyridyl)-3-phenylsuccinimide has been researched along with Leukemia in 1 studies
*Leukemia: A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006) [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Blettner, M; Erdmann, F; Gianicolo, E; Merzenich, H; Russo, A; Wollschlaeger, D | 1 |
1 other study(ies) available for n-(3-pyridyl)-3-phenylsuccinimide and Leukemia
| Article | Year |
|---|---|
Incidence of childhood leukemia before and after shut down of nuclear power plants in Germany in 2011: A population-based register study during 2004 to 2019.
Topics: Case-Control Studies; Child; Germany; Humans; Incidence; Leukemia; Nuclear Power Plants | 2023 |